Atlas Trials

Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy

Clinical trial NCT02788461 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02788461
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2016-05-01
Primary completion
2026-04-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.